What is Alzheimer's Disease?

Context: According to a new study, semaglutide, the active ingredient in popular blood sugar control and weight loss drugs, can reduce the risk of Alzheimer’s disease (AD) in people with type 2 diabetes. 

Major Highlights:

  • Early research on semaglutide identifies a number of ways in which it might benefit the brain, such as:
    • Lowering toxic effects of certain proteins linked to AD and improving how brain cells use glucose for energy.
    • Reducing the buildup of harmful plaques and tangles associated with Alzheimer’s.
    • Reducing neuro-inflammation, which is commonly linked to Alzheimer. 
  • Specifically, it was found to reduce the risk of a first-time Alzheimer’s diagnosis by 40% to 70%.
healthy brain vs Alzheimer's brain
Alzheimer's Disease neuron

Alzheimer’s disease: 

  • Alzheimer’s disease is a progressive neurologic disorder that causes the brain to shrink (atrophy) and brain cells to die. Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of dementia.
  • Causes: The disease is thought to be caused by the abnormal build-up of proteins in and around brain cells.
    • One of the proteins involved is called amyloid, deposits of which form plaques around brain cells.
    • The other protein is called tau, which is a deposit that forms tangles within brain cells.
  • Symptoms: Early signs include forgetting recent events/conversations. Later, the person will develop severe memory impairment and lose the ability to carry out everyday tasks. In the advanced stages, complications from severe loss of brain function result in death.
  • Treatment: Currently, there is no cure for Alzheimer’s disease, but certain medications can temporarily slow the worsening of dementia symptoms.
    • Traditionally, Alzheimer’s has been managed largely using cognitive and lifestyle interventions.
    • Recently, the US Food and Drug Administration (FDA) has approved two treatments — Biogen’s Leqembi and Eli Lilly’s Kisunla — that marginally slow the progression of AD by targeting the disease’s hallmark amyloid plaques in the brain. But these can cause serious side effects, including brain swelling and brain bleeding. 
Share this with friends ->

Leave a Reply

Your email address will not be published. Required fields are marked *

The maximum upload file size: 20 MB. You can upload: image, document, archive. Drop files here

Discover more from Compass by Rau's IAS

Subscribe now to keep reading and get access to the full archive.

Continue reading